glp 1 slow responder to GLP-1 Therapy Response Varies by Individual Factors Slow Responders on GLP-1: Why
Description
GLP-1 receptor agonists were developed primarily to treat type 2 diabetes and were later approved for chronic weight management
The most common compounded concentration is 2.5 mg/mL
Reddit sentiment is generally positive on price and pharmacy quality
The GLP-1 Drug Market's growth appears robust, with a projected valuation increase from 10.77 USD Billion in 2024 to 42.0 USD Billion by 2035
2025;14 doi: 10.3390/jcm14113791
Confirm whether the medication is compounded or FDA-approved
